These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 7565795
21. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway. Geppert TD, Whitehurst CE, Thompson P, Beutler B. Mol Med; 1994 Nov; 1(1):93-103. PubMed ID: 8790605 [Abstract] [Full Text] [Related]
22. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Khosravi-Far R, White MA, Westwick JK, Solski PA, Chrzanowska-Wodnicka M, Van Aelst L, Wigler MH, Der CJ. Mol Cell Biol; 1996 Jul; 16(7):3923-33. PubMed ID: 8668210 [Abstract] [Full Text] [Related]
23. Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src. Aziz N, Cherwinski H, McMahon M. Mol Cell Biol; 1999 Feb; 19(2):1101-15. PubMed ID: 9891045 [Abstract] [Full Text] [Related]
24. Activation of brain B-Raf protein kinase by Rap1B small GTP-binding protein. Ohtsuka T, Shimizu K, Yamamori B, Kuroda S, Takai Y. J Biol Chem; 1996 Jan 19; 271(3):1258-61. PubMed ID: 8576107 [Abstract] [Full Text] [Related]
25. The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. Tombes RM, Auer KL, Mikkelsen R, Valerie K, Wymann MP, Marshall CJ, McMahon M, Dent P. Biochem J; 1998 Mar 15; 330 ( Pt 3)(Pt 3):1451-60. PubMed ID: 9494119 [Abstract] [Full Text] [Related]
26. Biochemical analysis of MEK activation in NIH3T3 fibroblasts. Identification of B-Raf and other activators. Reuter CW, Catling AD, Jelinek T, Weber MJ. J Biol Chem; 1995 Mar 31; 270(13):7644-55. PubMed ID: 7706312 [Abstract] [Full Text] [Related]
27. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells. McCubrey JA, Steelman LS, Hoyle PE, Blalock WL, Weinstein-Oppenheimer C, Franklin RA, Cherwinski H, Bosch E, McMahon M. Leukemia; 1998 Dec 31; 12(12):1903-29. PubMed ID: 9844921 [Abstract] [Full Text] [Related]
28. Differential effects on cAMP on the MAP kinase cascade: evidence for a cAMP-insensitive step that can bypass Raf-1. Faure M, Bourne HR. Mol Biol Cell; 1995 Aug 31; 6(8):1025-35. PubMed ID: 7579705 [Abstract] [Full Text] [Related]
29. Interferons block protein kinase C-dependent but not-independent activation of Raf-1 and mitogen-activated protein kinases and mitogenesis in NIH 3T3 cells. Xu J, Rockow S, Kim S, Xiong W, Li W. Mol Cell Biol; 1994 Dec 31; 14(12):8018-27. PubMed ID: 7526152 [Abstract] [Full Text] [Related]
30. Inducible expression of a mutant form of MEK1 in Swiss 3T3 cells. Syu LJ, Guan KL, Saltiel AR. J Cell Biochem; 1997 Dec 01; 67(3):367-77. PubMed ID: 9361191 [Abstract] [Full Text] [Related]
31. MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos. Okazaki K, Sagata N. Oncogene; 1995 Mar 16; 10(6):1149-57. PubMed ID: 7700641 [Abstract] [Full Text] [Related]
32. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. Salmeron A, Ahmad TB, Carlile GW, Pappin D, Narsimhan RP, Ley SC. EMBO J; 1996 Feb 15; 15(4):817-26. PubMed ID: 8631303 [Abstract] [Full Text] [Related]
33. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway. Woods D, Cherwinski H, Venetsanakos E, Bhat A, Gysin S, Humbert M, Bray PF, Saylor VL, McMahon M. Mol Cell Biol; 2001 May 15; 21(9):3192-205. PubMed ID: 11287623 [Abstract] [Full Text] [Related]
34. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Pumiglia KM, Decker SJ. Proc Natl Acad Sci U S A; 1997 Jan 21; 94(2):448-52. PubMed ID: 9012803 [Abstract] [Full Text] [Related]
35. A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. Schaap D, van der Wal J, Howe LR, Marshall CJ, van Blitterswijk WJ. J Biol Chem; 1993 Sep 25; 268(27):20232-6. PubMed ID: 8397201 [Abstract] [Full Text] [Related]
36. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Schönwasser DC, Marais RM, Marshall CJ, Parker PJ. Mol Cell Biol; 1998 Feb 25; 18(2):790-8. PubMed ID: 9447975 [Abstract] [Full Text] [Related]
37. A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function. Catling AD, Schaeffer HJ, Reuter CW, Reddy GR, Weber MJ. Mol Cell Biol; 1995 Oct 25; 15(10):5214-25. PubMed ID: 7565670 [Abstract] [Full Text] [Related]
38. A dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells. Seternes OM, Johansen B, Moens U. Mol Endocrinol; 1999 Jul 25; 13(7):1071-83. PubMed ID: 10406459 [Abstract] [Full Text] [Related]
39. Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells. Weissinger EM, Eissner G, Grammer C, Fackler S, Haefner B, Yoon LS, Lu KS, Bazarov A, Sedivy JM, Mischak H, Kolch W. Mol Cell Biol; 1997 Jun 25; 17(6):3229-41. PubMed ID: 9154822 [Abstract] [Full Text] [Related]
40. Growth factor induced MEK activation is primarily mediated by an activator different from c-raf. Zheng CF, Ohmichi M, Saltiel AR, Guan KL. Biochemistry; 1994 May 10; 33(18):5595-9. PubMed ID: 8180183 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]